author-photo

Linda K. Thompson

Eli Lilly and Company

12

Papers

751

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Preclinical profile of a dopamine D1 potentiator suggests therapeutic utility in neurological and psychiatric disorders

2018 Neuropharmacology
Show All
- Source
- Cite
- Save
Citations (24)
Inquiries into the Biological Significance of Transmembrane AMPA Receptor Regulatory Protein (TARP) γ−8 Through Investigations of TARP γ−8 Null Mice§

2015 Cns & Neurological Disorders-drug Targets
Show All
- Source
- Cite
- Save
Citations (9)
Discovery of a potent, dual serotonin and norepinephrine reuptake inhibitor.

2013 ACS Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (9)
Monoaminergic compensation in the neuropeptide Y deficient mouse brain

2008 Neuropeptides
Show All
- Source
- Cite
- Save
Citations (18)
The Orexin-1 Antagonist SB-334867 Blocks Antipsychotic Treatment–Emergent Catalepsy: Implications for the Treatment of Extrapyramidal Symptoms

2006 Schizophrenia Bulletin
Show All
- Source
- Cite
- Save
Citations (12)
Discovery of novel and selective tertiary alcohol containing inhibitors of the norepinephrine transporter

2006 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (16)
Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats

2003 Neuropharmacology
Show All
- Source
- Cite
- Save
Citations (110)
Comparative Affinity of Duloxetine and Venlafaxine for Serotonin and Norepinephrine Transporters in vitro and in vivo , Human Serotonin Receptor Subtypes, and Other Neuronal Receptors

2001 Neuropsychopharmacology
Show All
- Source
- Cite
- Save
Citations (452)